US Stock MarketDetailed Quotes

CLRB Cellectar BioSciences

Watchlist
  • 1.6200
  • +0.0400+2.53%
Trading Nov 25 13:54 ET
66.86MMarket Cap-1148P/E (TTM)

Cellectar BioSciences Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
41.58%13.33M
65.22%13.7M
37.86%12M
35.22%38.96M
69.05%12.55M
20.45%9.41M
11.55%8.29M
41.77%8.71M
19.40%28.81M
25.31%7.42M
Selling and administrative expenses
229.33%7.83M
194.50%6.36M
109.44%4.91M
10.87%11.69M
64.59%4.81M
-2.32%2.38M
-26.49%2.16M
4.12%2.35M
61.17%10.55M
90.37%2.92M
-General and administrative expense
229.33%7.83M
194.50%6.36M
109.44%4.91M
10.87%11.69M
64.59%4.81M
-2.32%2.38M
-26.49%2.16M
4.12%2.35M
61.17%10.55M
90.37%2.92M
Research and development costs
-21.91%5.49M
19.73%7.35M
11.46%7.09M
49.28%27.27M
71.95%7.74M
30.75%7.03M
36.37%6.14M
63.60%6.36M
3.86%18.27M
2.55%4.5M
Operating profit
-41.58%-13.33M
-65.22%-13.7M
-37.86%-12M
-35.22%-38.96M
-69.05%-12.55M
-20.45%-9.41M
-11.55%-8.29M
-41.77%-8.71M
-19.40%-28.81M
-25.31%-7.42M
Net non-operating interest income expense
521.97%317.89K
351.92%328.91K
157.87%319.85K
153.84%387.15K
-5.58%139.22K
1,127.43%51.11K
15,030.98%72.78K
28,745.12%124.03K
6,577.71%152.52K
11,211.08%147.44K
Non-operating interest income
521.97%317.89K
351.92%328.91K
157.87%319.85K
153.84%387.15K
-5.58%139.22K
1,127.43%51.11K
15,030.98%72.78K
28,745.12%124.03K
6,577.71%152.52K
11,211.08%147.44K
Other net income (expense)
79.71%-1.65M
736.32%12.46M
-1,175.67%-14.96M
-33.39%-4.26M
4.47M
-8.16M
-1.96M
1.39M
-48,206.18%-3.19M
Gain on sale of security
179.19%6.09M
736.32%12.46M
-1,175.67%-14.96M
-204.24%-3.79M
--4.47M
---7.69M
---1.96M
--1.39M
--3.63M
----
Other non- operating income (expenses)
-1,547.51%-7.74M
----
----
93.11%-470K
--0
---470K
----
----
-102,973.15%-6.82M
----
Income before tax
16.30%-14.66M
90.97%-919.37K
-270.52%-26.64M
-34.46%-42.83M
24.13%-7.94M
-124.29%-17.52M
-36.90%-10.18M
-17.11%-7.19M
-32.05%-31.85M
-76.86%-10.47M
Income tax
0.00%-60K
-60K
Net income
16.30%-14.66M
90.97%-919.37K
-270.52%-26.64M
-34.53%-42.77M
24.27%-7.88M
-124.29%-17.52M
-36.90%-10.18M
-17.11%-7.19M
-31.80%-31.79M
-75.84%-10.41M
Net income continuous Operations
16.30%-14.66M
90.97%-919.37K
-270.52%-26.64M
-34.53%-42.77M
24.27%-7.88M
-124.29%-17.52M
-36.90%-10.18M
-17.11%-7.19M
-31.80%-31.79M
-75.84%-10.41M
Minority interest income
Net income attributable to the parent company
16.30%-14.66M
90.97%-919.37K
-270.52%-26.64M
-34.53%-42.77M
24.27%-7.88M
-124.29%-17.52M
-36.90%-10.18M
-17.11%-7.19M
-31.80%-31.79M
-75.84%-10.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.30%-14.66M
90.97%-919.37K
-270.52%-26.64M
-34.53%-42.77M
24.27%-7.88M
-124.29%-17.52M
-36.90%-10.18M
-17.11%-7.19M
-31.80%-31.79M
-75.84%-10.41M
Basic earnings per share
76.13%-0.37
96.67%-0.03
-42.19%-0.91
22.39%-3.5
59.41%-0.41
-21.09%-1.55
26.23%-0.9
36.00%-0.64
-3.68%-4.51
-5.21%-1.01
Diluted earnings per share
74.19%-0.4
80.00%-0.18
-42.19%-0.91
22.39%-3.5
59.41%-0.41
-21.09%-1.55
26.23%-0.9
36.00%-0.64
-3.68%-4.51
-5.21%-1.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 41.58%13.33M65.22%13.7M37.86%12M35.22%38.96M69.05%12.55M20.45%9.41M11.55%8.29M41.77%8.71M19.40%28.81M25.31%7.42M
Selling and administrative expenses 229.33%7.83M194.50%6.36M109.44%4.91M10.87%11.69M64.59%4.81M-2.32%2.38M-26.49%2.16M4.12%2.35M61.17%10.55M90.37%2.92M
-General and administrative expense 229.33%7.83M194.50%6.36M109.44%4.91M10.87%11.69M64.59%4.81M-2.32%2.38M-26.49%2.16M4.12%2.35M61.17%10.55M90.37%2.92M
Research and development costs -21.91%5.49M19.73%7.35M11.46%7.09M49.28%27.27M71.95%7.74M30.75%7.03M36.37%6.14M63.60%6.36M3.86%18.27M2.55%4.5M
Operating profit -41.58%-13.33M-65.22%-13.7M-37.86%-12M-35.22%-38.96M-69.05%-12.55M-20.45%-9.41M-11.55%-8.29M-41.77%-8.71M-19.40%-28.81M-25.31%-7.42M
Net non-operating interest income expense 521.97%317.89K351.92%328.91K157.87%319.85K153.84%387.15K-5.58%139.22K1,127.43%51.11K15,030.98%72.78K28,745.12%124.03K6,577.71%152.52K11,211.08%147.44K
Non-operating interest income 521.97%317.89K351.92%328.91K157.87%319.85K153.84%387.15K-5.58%139.22K1,127.43%51.11K15,030.98%72.78K28,745.12%124.03K6,577.71%152.52K11,211.08%147.44K
Other net income (expense) 79.71%-1.65M736.32%12.46M-1,175.67%-14.96M-33.39%-4.26M4.47M-8.16M-1.96M1.39M-48,206.18%-3.19M
Gain on sale of security 179.19%6.09M736.32%12.46M-1,175.67%-14.96M-204.24%-3.79M--4.47M---7.69M---1.96M--1.39M--3.63M----
Other non- operating income (expenses) -1,547.51%-7.74M--------93.11%-470K--0---470K---------102,973.15%-6.82M----
Income before tax 16.30%-14.66M90.97%-919.37K-270.52%-26.64M-34.46%-42.83M24.13%-7.94M-124.29%-17.52M-36.90%-10.18M-17.11%-7.19M-32.05%-31.85M-76.86%-10.47M
Income tax 0.00%-60K-60K
Net income 16.30%-14.66M90.97%-919.37K-270.52%-26.64M-34.53%-42.77M24.27%-7.88M-124.29%-17.52M-36.90%-10.18M-17.11%-7.19M-31.80%-31.79M-75.84%-10.41M
Net income continuous Operations 16.30%-14.66M90.97%-919.37K-270.52%-26.64M-34.53%-42.77M24.27%-7.88M-124.29%-17.52M-36.90%-10.18M-17.11%-7.19M-31.80%-31.79M-75.84%-10.41M
Minority interest income
Net income attributable to the parent company 16.30%-14.66M90.97%-919.37K-270.52%-26.64M-34.53%-42.77M24.27%-7.88M-124.29%-17.52M-36.90%-10.18M-17.11%-7.19M-31.80%-31.79M-75.84%-10.41M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.30%-14.66M90.97%-919.37K-270.52%-26.64M-34.53%-42.77M24.27%-7.88M-124.29%-17.52M-36.90%-10.18M-17.11%-7.19M-31.80%-31.79M-75.84%-10.41M
Basic earnings per share 76.13%-0.3796.67%-0.03-42.19%-0.9122.39%-3.559.41%-0.41-21.09%-1.5526.23%-0.936.00%-0.64-3.68%-4.51-5.21%-1.01
Diluted earnings per share 74.19%-0.480.00%-0.18-42.19%-0.9122.39%-3.559.41%-0.41-21.09%-1.5526.23%-0.936.00%-0.64-3.68%-4.51-5.21%-1.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data